Integrated Advisors Network’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Integrated Advisors Network's BIIB Position: Q2 2026 in Review
Integrated Advisors Network reduced its Biogen (BIIB) stake by 23% in Q2 2026, selling an estimated $78.8K and leaving 1,355 shares worth $293K. The position accounts for 0.01% of the portfolio, ranked #575.
Integrated Advisors Network first reported a position in BIIB in Q4 2019 and has held it in 20 quarters since. The position peaked at $580K in Q2 2024. 1,045 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Integrated Advisors Network held 1,355 shares of Biogen worth $293K as of Q2 2026.
- Integrated Advisors Network sold 412 Biogen shares in Q2 2026, an estimated $78.8K.
- Biogen made up 0.01% of Integrated Advisors Network's portfolio in Q2 2026, its #575 holding.
- Integrated Advisors Network first reported a position in Biogen in Q4 2019 and has held it in 20 quarters since.
- Integrated Advisors Network's Biogen position peaked at $580K in Q2 2024.
- 1,045 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Integrated Advisors Network's 13F filing for Q2 2026, filed 11 Aug 2026.